Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Mar;59(3):325–326. doi: 10.1038/bjc.1989.64

Continuous, hyperfractionated, accelerated radiotherapy (CHART).

S Dische 1, M I Saunders 1
PMCID: PMC2247093  PMID: 2649133

Full text

PDF
325

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Begg A. C., McNally N. J., Shrieve D. C., Kärcher H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry. 1985 Nov;6(6):620–626. doi: 10.1002/cyto.990060618. [DOI] [PubMed] [Google Scholar]
  2. Begg A. C., Moonen L., Hofland I., Dessing M., Bartelink H. Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations. Radiother Oncol. 1988 Apr;11(4):337–347. doi: 10.1016/0167-8140(88)90205-8. [DOI] [PubMed] [Google Scholar]
  3. Denekamp J. Cell kinetics and radiation biology. Int J Radiat Biol Relat Stud Phys Chem Med. 1986 Feb;49(2):357–380. doi: 10.1080/09553008514552591. [DOI] [PubMed] [Google Scholar]
  4. Fowler J. F. Potential for increasing the differential response between tumors and normal tissues: can proliferation rate be used? Int J Radiat Oncol Biol Phys. 1986 Apr;12(4):641–645. doi: 10.1016/0360-3016(86)90074-x. [DOI] [PubMed] [Google Scholar]
  5. Peracchia G., Salti C. Radiotherapy with thrice-a-day fractionation in a short overall time: clinical experiences. Int J Radiat Oncol Biol Phys. 1981 Jan;7(1):99–104. doi: 10.1016/0360-3016(81)90065-1. [DOI] [PubMed] [Google Scholar]
  6. Perez C. A., Stanley K., Grundy G., Hanson W., Rubin P., Kramer S., Brady L. W., Marks J. E., Perez-Tamayo R., Brown G. S. Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung: report by the Radiation Therapy Oncology Group. Cancer. 1982 Sep 15;50(6):1091–1099. doi: 10.1002/1097-0142(19820915)50:6<1091::aid-cncr2820500612>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  7. Saunders M. I., Dische S., Fowler J. F., Denekamp J., Dunphy E. P., Grosch E., Fermont D., Ashford R., Maher J., Des Rochers C. Radiotherapy employing three fractions on each of twelve consecutive days. Acta Oncol. 1988;27(2):163–167. doi: 10.3109/02841868809090336. [DOI] [PubMed] [Google Scholar]
  8. Saunders M. I., Dische S. Radiotherapy employing three fractions in each day over a continuous period of 12 days. Br J Radiol. 1986 May;59(701):523–525. doi: 10.1259/0007-1285-59-701-523. [DOI] [PubMed] [Google Scholar]
  9. Schaake-Koning C., Schuster-Uitterhoeve L., Hart G., Gonzalez Gonzalez D. Prognostic factors of inoperable localized lung cancer treated by high dose radiotherapy. Int J Radiat Oncol Biol Phys. 1983 Jul;9(7):1023–1028. doi: 10.1016/0360-3016(83)90392-9. [DOI] [PubMed] [Google Scholar]
  10. Trott K. R., Kummermehr J. What is known about tumour proliferation rates to choose between accelerated fractionation or hyperfractionation? Radiother Oncol. 1985 Jan;3(1):1–9. doi: 10.1016/s0167-8140(85)80002-5. [DOI] [PubMed] [Google Scholar]
  11. Van den Bogaert W., van der Schueren E., Horiot J. C., Chaplain G., Arcangeli G., Gonzalez D., Svoboda V. The feasibility of high-dose multiple daily fractionation and its combination with anoxic cell sensitizers in the treatment of head and neck cancer. A pilot study of the Radiotherapy Group of the EORTC (European Organisation for Research on Treatment of Cancer). Int J Radiat Oncol Biol Phys. 1982 Oct;8(10):1649–1655. doi: 10.1016/0360-3016(82)90282-6. [DOI] [PubMed] [Google Scholar]
  12. Wang C. C., Suit H. D., Blitzer P. H. Twice-a-day radiation therapy for supraglottic carcinoma. Int J Radiat Oncol Biol Phys. 1986 Jan;12(1):3–7. doi: 10.1016/0360-3016(86)90407-4. [DOI] [PubMed] [Google Scholar]
  13. Wilson G. D., McNally N. J., Dische S., Bennett M. H. Cell proliferation in human tumours measured by in-vivo labelling with bromodeoxyuridine. Br J Radiol. 1988 May;61(725):419–422. doi: 10.1259/0007-1285-61-725-419. [DOI] [PubMed] [Google Scholar]
  14. Wilson G. D., McNally N. J., Dunphy E., Kärcher H., Pfragner R. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry. Cytometry. 1985 Nov;6(6):641–647. doi: 10.1002/cyto.990060621. [DOI] [PubMed] [Google Scholar]
  15. Withers H. R., Taylor J. M., Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 1988;27(2):131–146. doi: 10.3109/02841868809090333. [DOI] [PubMed] [Google Scholar]
  16. van den Berg-Rust C. J. Uitslag Ewing-screening onvoldoende--en dan? Ned Tijdschr Geneeskd. 1986 Nov 1;130(44):1986–1988. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES